Abstract
The mutual correlation among soluble CD4 (sCD4), soluble CD8 (sCD8), and soluble CD23 (sCD23) has not yet been studied in patients with rheumatoid arthritis (RA), although previous studies have demonstrated that certain soluble markers of immune activation are elevated in RA. Thus, we examined this correlation based on the serum levels of sCD4, sCD8 and sCD23, and that of their levels with other serum markers such as immunoglobulin (Ig) subtypes (IgG, IgM and IgA), IgM-rheumatoid factor (IgM-RF) and C-reactive protein (CRP) in 25 RA patients, sCD4 was not elevated, whereas both sCD8 and sCD23 increased in RA patients compared with the healthy controls; a majority of RA patients, in particular, showed a high sCD23 level. The level of sCD23 showed a correlation with that of IgM-RF, but not with those of IgG, IgM, IgA and CRP. Importantly, a high level of sCD23 was not always accompartied with that of sCD8. The independent change between sCD23 and sCD8 levels was also observed in a one-year follow-up study of the two RA patients. These findings indicate that B cells might be generally activated in RA, whereas T-cell activation in variable in each patient with RA, suggesting that sCD23 is a more indicative marker for the immune status of RA patients than sCD8 from the clinical aspects.
Full Text
The Full Text of this article is available as a PDF (286.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armant M., Ishihara H., Rubio M., Delespesse G., Sarfati M. Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J Exp Med. 1994 Sep 1;180(3):1005–1011. doi: 10.1084/jem.180.3.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
- Chomarat P., Briolay J., Banchereau J., Miossec P. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Arthritis Rheum. 1993 Feb;36(2):234–242. doi: 10.1002/art.1780360215. [DOI] [PubMed] [Google Scholar]
- Firestein G. S., Tsai V., Zvaifler N. J. Cellular immunity in the joints of patients with rheumatoid arthritis and other forms of chronic synovitis. Rheum Dis Clin North Am. 1987 Aug;13(2):191–213. [PubMed] [Google Scholar]
- Gordon J. CD23 and B cell activation. Clin Exp Allergy. 1992 Feb;22(2):199–204. doi: 10.1111/j.1365-2222.1992.tb03073.x. [DOI] [PubMed] [Google Scholar]
- Panayi G. S., Lanchbury J. S., Kingsley G. H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 1992 Jul;35(7):729–735. doi: 10.1002/art.1780350702. [DOI] [PubMed] [Google Scholar]
- Ruschen S., Stellberg W., Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol. 1992 Jul;89(1):32–37. doi: 10.1111/j.1365-2249.1992.tb06873.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaughan J. H., Chihara T., Moore T. L., Robbins D. L., Tanimoto K., Johnson J. S., McMillan R. Rheumatoid factor-producing cells detected by direct hemolytic plaque assay. J Clin Invest. 1976 Oct;58(4):933–941. doi: 10.1172/JCI108546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westacott C. I., Whicher J. T., Barnes I. C., Thompson D., Swan A. J., Dieppe P. A. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis. 1990 Sep;49(9):676–681. doi: 10.1136/ard.49.9.676. [DOI] [PMC free article] [PubMed] [Google Scholar]